New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient.